Kristin Karlsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristin Karlsson has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Elias Lindbäck
Section of Radiotherapy Physics and Engineering, Department of Nuclear Medicine and Medical Physics, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
2 shared publicationsIngmar Lax
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden
2 shared publicationsAlessandro Scaggion
Medical Physics Department, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy
1 shared publicationAljasa Jenko
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
1 shared publicationAndré Haraldsson
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
1 shared publicationAnne-Sofie Frøland
Department of Oncology, Oslo University Hospital, Oslo, Norway
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (5) , 055015
Should breast/thoracic wall and lymph node volumes have the same margin in hypofractionated radiotherapy?
Purpose. The aim of this study was to investigate if the same planning target volume margins should be used for the breast/thoracic wall and lymph nodes when treated simultaneously with hypofractionated radiotherapy in deep inspiration breath-hold (DIBH) and free breathing (FB). Methods. For 80 patients (40 treated in FB and 40 in DIBH), nine anatomy sites were evaluated. Three were located in relation to the lymph node region and six in relation to the breast/thoracic wall. For three treatment fractions, a cone beam CT was acquired before and after the treatment and compared to the planning CT. Margins were calculated based on the inter- and intra-fractional uncertainties, ensuring 90% of the patients receiving 95% of the prescribed dose to the clinical target volume. Margin calculation was done for the full patient data set as well as for a subgroup of patients with set-up errors below the clinical action level, excluding patients with set-up errors larger than 7 mm. Results. For the full patient data set, margins of up to 14 mm were calculated. However, for patients with set-up errors below the clinical action level, the largest margins calculated for the lymph node region for treatments in DIBH were 8.5 mm, 8.7 mm and 6.6 mm in the vertical, longitudinal, and lateral directions respectively compared to 8.4 mm, 7.9 mm and 5.9 mm for treatments in FB. For the breast/thoracic wall, the largest margins were 5.9 mm, 6.4 mm and 5.5 mm for treatments in DIBH and 5.8 mm, 7.2 mm and 5.8 mm for treatments in FB in the vertical, longitudinal and lateral directions respectively. Conclusion. Treatments in DIBH and FB can use the same margins. However, the lymph node region requires a larger margin than the breast/thoracic wall region, due to greater anatomical mobility.
- 17 September 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (5) , 055015
Open AccessShould breast/thoracic wall and lymph node volumes have the same margin in hypofractionated radiotherapy?
Purpose. The aim of this study was to investigate if the same planning target volume margins should be used for the breast/thoracic wall and lymph nodes when treated simultaneously with hypofractionated radiotherapy in deep inspiration breath-hold (DIBH) and free breathing (FB). Methods. For 80 patients (40 treated in FB and 40 in DIBH), nine anatomy sites were evaluated. Three were located in relation to the lymph node region and six in relation to the breast/thoracic wall. For three treatment fractions, a cone beam CT was acquired before and after the treatment and compared to the planning CT. Margins were calculated based on the inter- and intra-fractional uncertainties, ensuring 90% of the patients receiving 95% of the prescribed dose to the clinical target volume. Margin calculation was done for the full patient data set as well as for a subgroup of patients with set-up errors below the clinical action level, excluding patients with set-up errors larger than 7 mm. Results. For the full patient data set, margins of up to 14 mm were calculated. However, for patients with set-up errors below the clinical action level, the largest margins calculated for the lymph node region for treatments in DIBH were 8.5 mm, 8.7 mm and 6.6 mm in the vertical, longitudinal, and lateral directions respectively compared to 8.4 mm, 7.9 mm and 5.9 mm for treatments in FB. For the breast/thoracic wall, the largest margins were 5.9 mm, 6.4 mm and 5.5 mm for treatments in DIBH and 5.8 mm, 7.2 mm and 5.8 mm for treatments in FB in the vertical, longitudinal and lateral directions respectively. Conclusion. Treatments in DIBH and FB can use the same margins. However, the lymph node region requires a larger margin than the breast/thoracic wall region, due to greater anatomical mobility.
- Open Access
- 14 January 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (5) , 1298-1308
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort
- 14 January 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (5) , 1298-1308
Open AccessDose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort
- 1 May 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 196, 110318
Treatment planning and delivery practice of lung SBRT: Results of the 2022 ESTRO physics survey
- 1 May 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 196, 110318
Treatment planning and delivery practice of lung SBRT: Results of the 2022 ESTRO physics survey
- Open Access
- 7 October 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 28, 100499
Abdominal compression as motion management for stereotactic radiotherapy of ventricular tachycardia
- 7 October 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 28, 100499
Open AccessAbdominal compression as motion management for stereotactic radiotherapy of ventricular tachycardia
- 7 April 2017
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 56 (9) , 1189-1196
Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions
Introduction: Geometrical uncertainties can result in a delivered dose to the tumor different from that estimated in the static treatment plan. The purpose of this project was to investigate the accuracy of the dose calculated to the clinical target volume (CTV) with the dose-shift approximation, in stereotactic body radiation therapy (SBRT) of lung tumors considering setup errors and breathing motion. The dose-shift method was compared with a beam-shift method with dose recalculation. Material and methods: Included were 10 patients (10 tumors) selected to represent a variety of SBRT-treated lung tumors in terms of tumor location, CTV volume, and tumor density. An in-house developed toolkit within a treatment planning system allowed the shift of either the dose matrix or a shift of the beam isocenter with dose recalculation, to simulate setup errors and breathing motion. Setup shifts of different magnitudes (up to 10 mm) and directions as well as breathing with different peak-to-peak amplitudes (up to 10:5:5 mm) were modeled. The resulting dose–volume histograms (DVHs) were recorded and dose statistics were extracted. Results: Generally, both the dose-shift and beam-shift methods resulted in calculated doses lower than the static planned dose, although the minimum (D98%) dose exceeded the prescribed dose in all cases, for setup shifts up to 5 mm. The dose-shift method also generally underestimated the dose compared with the beam-shift method. For clinically realistic systematic displacements of less than 5 mm, the results demonstrated that in the minimum dose region within the CTV, the dose-shift method was accurate to 2% (root-mean-square error). Breathing motion only marginally degraded the dose distributions. Conclusions: Averaged over the patients and shift directions, the dose-shift approximation was determined to be accurate to approximately 2% (RMS) within the CTV, for clinically relevant geometrical uncertainties for SBRT of lung tumors.
- 7 April 2017
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 56 (9) , 1189-1196
Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions
Introduction: Geometrical uncertainties can result in a delivered dose to the tumor different from that estimated in the static treatment plan. The purpose of this project was to investigate the accuracy of the dose calculated to the clinical target volume (CTV) with the dose-shift approximation, in stereotactic body radiation therapy (SBRT) of lung tumors considering setup errors and breathing motion. The dose-shift method was compared with a beam-shift method with dose recalculation. Material and methods: Included were 10 patients (10 tumors) selected to represent a variety of SBRT-treated lung tumors in terms of tumor location, CTV volume, and tumor density. An in-house developed toolkit within a treatment planning system allowed the shift of either the dose matrix or a shift of the beam isocenter with dose recalculation, to simulate setup errors and breathing motion. Setup shifts of different magnitudes (up to 10 mm) and directions as well as breathing with different peak-to-peak amplitudes (up to 10:5:5 mm) were modeled. The resulting dose–volume histograms (DVHs) were recorded and dose statistics were extracted. Results: Generally, both the dose-shift and beam-shift methods resulted in calculated doses lower than the static planned dose, although the minimum (D98%) dose exceeded the prescribed dose in all cases, for setup shifts up to 5 mm. The dose-shift method also generally underestimated the dose compared with the beam-shift method. For clinically realistic systematic displacements of less than 5 mm, the results demonstrated that in the minimum dose region within the CTV, the dose-shift method was accurate to 2% (root-mean-square error). Breathing motion only marginally degraded the dose distributions. Conclusions: Averaged over the patients and shift directions, the dose-shift approximation was determined to be accurate to approximately 2% (RMS) within the CTV, for clinically relevant geometrical uncertainties for SBRT of lung tumors.